Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
DELCATH SYSTEMS, INC. (DCTH)
|
Add to portfolio |
|
|
|
| Price: |
$12.93
| | Metrics |
| OS: |
15.3
|
M
| |
|
|
| Market cap: |
$198
|
M
| |
|
|
|
Net debt:
|
$11.4
|
M
| |
|
|
|
EV:
|
$209
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($34.1)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 2.7 | 3.6 | 0.4 | 0.1 | 1.4 | 1.3 | 2.0 | 1.7 |
| Revenue growth | -23.5% | 871.3% | 157.7% | -89.8% | 5.8% | -34.1% | 14.0% | 63.4% |
| Cost of goods sold | 0.7 | 0.7 | -0.6 | -0.7 | -1.0 | -0.7 | 0.6 | 0.5 |
| Gross profit | 2.0 | 2.9 | 1.0 | 0.9 | 2.4 | 2.0 | 1.4 | 1.3 |
| Gross margin | 74.8% | 81.1% | 274.9% | 606.3% | 172.6% | 153.4% | 72.4% | 73.6% |
| Selling, general and administrative | 17.3 | 13.6 | 11.1 | 11.3 | 9.8 | 9.7 | 9.4 | 10.0 |
| Research and development | 18.6 | 13.8 | 11.2 | 9.5 | 19.7 | 10.5 | 8.4 | 6.5 |
| EBIT | -33.9 | -24.5 | -24.1 | -2.4 | -7.4 | -3.1 | -3.7 | -14.6 |
| EBIT margin | -1245.1% | -690.0% | -6594.3% | -1697.2% | -530.2% | -233.2% | -183.7% | -838.4% |
| Pre-tax income | -36.5 | -25.6 | -24.2 | -8.9 | -19.2 | -45.1 | -18.0 | -14.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -36.5 | -25.6 | -24.2 | -8.9 | -19.2 | -45.1 | -18.0 | -14.7 |
| Net margin | -1342.4% | -721.5% | -6600.0% | -6252.8% | -1383.9% | -3436.2% | -902.2% | -841.7% |
| |
| Diluted EPS | ($4.12) | ($3.59) | ($8.34) | ($342.82) | ($503.84) | ($3,213.69) | ($3,707.65) | ($5,093.18) |
| Shares outstanding (diluted) | 8.9 | 7.1 | 2.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|